News & Insights

How HCPs Use AI Search: 7 Behavioral Shifts Pharma Marketers Need to Plan For in 2026

Q: What is HCP AI search behavior, and why does it matter for pharma marketing?

HCP AI search behavior refers to the specific ways physicians, PAs, NPs, MSLs, and pharmacists use AI tools like ChatGPT, Perplexity, Claude, and specialty models such as OpenEvidence during clinical decision moments. It matters because these tools are now a genuine entry point into how HCPs form impressions of a brand, a mechanism, or a safety profile, often before they ever visit a brand website directly.

Q: What is the difference between OpenEvidence and ChatGPT for clinical use?

OpenEvidence is built specifically for evidence-based clinical questions and draws heavily on indexed medical literature with visible citations, while ChatGPT is a general-purpose model used for a wider range of tasks, including drafting and general orientation, with less consistent sourcing for clinical claims.

Q: How can pharma brands track whether they show up in AI-generated answers?

Brands can systematically query the same AI tools their HCP audience uses, across a defined set of clinical and branded questions by indication, and track whether their content, a competitor's content, or no branded source appears in the answer. This should be repeated regularly, since AI answers shift as models update and as content changes.

Last Updated: July 30, 2026

A cardiologist finishing a clinic note now asks a chatbot to summarize a trial before she asks a colleague. A pharmacist checks an interaction with a specialty medical model instead of flipping through a binder. Pharma marketers still planning around search results pages are already a step behind the physicians they are trying to reach.

TL;DR

HCPs now use a mix of general consumer AI tools like ChatGPT and Perplexity alongside specialty medical models like OpenEvidence and Consensus, often within the same clinical decision. This shift changes what content earns visibility: brand mentions inside an AI answer now matter as much as ranking position, structured and citation-worthy data pages outperform static PDFs, and safety information needs to be extractable rather than locked in a document. Pharma marketers need to measure share of voice inside AI answers by indication, fix crawlability and schema gaps on brand sites, and build an MLR review path specifically for AI-answer surfaces this quarter.

How AI search actually shows up in the clinical day
The 7 behavioral shifts pharma marketers need to plan for
What pharma should measure now
What to fix on your brand site this quarter
The MLR question: approving content for AI-answer surfaces
FAQ
Related Reading
Let's Talk HCP AI Search

How AI search actually shows up in the clinical day

AI in healthcare marketing conversations tend to focus on chatbots as a novelty. On the clinical floor, they are already a utility layered into ordinary tasks.

Dictation is the most invisible entry point. Ambient scribe tools built on large language models draft notes in real time, and many surface a quick clinical reference inline when a physician mentions a medication or lab value. The AI is not just transcribing, it is quietly annotating.

Differential diagnosis support is next. A physician working through an unusual presentation will type symptoms into a model to see what comes back, not to replace judgment but to make sure nothing obvious was missed. Patient-question rephrasing is a quieter but common use: physicians ask an AI tool to draft a plain-language explanation for a patient question, then edit and deliver it. Drug interaction lookups follow a similar pattern, often faster than the tools bundled into the electronic health record.

Guideline synthesis rounds this out. Instead of digging through a full guideline document, physicians ask an AI tool to summarize what changed, then click through to confirm the source if the stakes are high enough. Each moment is a place where your brand's content either shows up in the answer or does not exist as far as the clinician is concerned.

The 7 behavioral shifts pharma marketers need to plan for

These are patterns in how doctors use ChatGPT, Perplexity, Claude, and specialty tools, each with a direct implication for brand strategy.

1. HCPs ask general consumer models first, then verify with clinical sources

Reaching for ChatGPT or Perplexity before opening a clinical database is now common, even among physicians who describe themselves as cautious about AI. The general model is faster and often good enough for initial orientation before the clinician moves to a trusted source to confirm. Implication: your consumer-facing DTC page might get pulled into that first answer before your HCP page ever enters the picture, simply because the DTC page is more crawlable and written in more retrievable language.

2. Perplexity is the quick check for guideline updates

Physicians increasingly reach for Perplexity when they want to know what changed in a guideline since they last read it, because the tool shows its sources inline and lets them jump straight to the primary document. If your content does not cite the current guideline near the top of the page, it is less likely to be the source that gets surfaced. Guideline content needs a visible publication date and a clear statement of which version it reflects.

3. ChatGPT with browsing is the brief prep tool for CME and panel discussions

When an HCP preps for a CME session or a panel discussion, ChatGPT's browsing mode gets used to build a working brief on a mechanism or recent data readout. This favors long-form, authoritative content over short pages, because the model is synthesizing depth, not just retrieving a fact. A thin FAQ page will not get pulled into this kind of prep. A comprehensive mechanism-of-action page with real citations will.

4. Specialty models are gaining share in evidence lookups

OpenEvidence, Consensus, and similar tools are becoming a default first stop for evidence-based questions, particularly for physicians who want a citation trail built for clinical use. These tools often pull from indexed academic literature rather than the open web, so your data pages need to be structured for both web crawlers and academic-style indexing. A page that only renders for a browser, with data locked in an image or chart, is invisible to this class of tool.

5. Voice AI is entering the exam room

Ambient listening and voice AI tools are moving from note-taking assistants toward tools that summarize a drug's key facts out loud, mid-conversation, with a patient present. Your key claims need to be written so they hold up when compressed into a spoken sentence by a model that is summarizing, not quoting verbatim. A claim that only makes sense with three qualifying clauses will not survive verbal summarization intact, a risk medical, legal, and regulatory reviewers should weigh now.

6. HCPs are less brand-loyal at the point of AI query

Search habits used to reward brands that trained physicians to type a specific branded URL. AI answers flatten that advantage. A physician asking about a drug class gets an answer pulled from whichever sources the model trusts and can retrieve cleanly, regardless of whether that source is your site or a competitor's. Being mentioned favorably inside the answer now matters more than where your page ranks on a results page fewer HCPs are even scrolling through.

7. Real-world safety questions bypass the ISI entirely

When a physician or patient asks an AI tool about a side effect, the model answers from whatever structured content it can find, and a scanned or image-based Important Safety Information PDF usually is not it. If your safety profile only exists as a PDF, AI tools answer safety questions without your official language in the mix at all. Safety data needs a structured, extractable, on-page equivalent a model can retrieve and quote.

What pharma should measure now

Traditional SEO reporting cannot answer the question every brand team is now asking: are we showing up in the AI answer at all. Three measurement priorities matter most.

Share of voice in AI answers by indication. Ask the same questions a physician would ask, across ChatGPT, Perplexity, Claude, and specialty tools, and track whether your brand, a competitor, or no branded source shows up. Track this by indication and query type, since a brand can dominate one question type and disappear on another.

Competitive citation gap. Where a competitor's content is cited more often than yours, that gap is a content and structure problem, not a media buying problem. Understanding which pages get pulled, and why, tells you what to build or fix.

Sentiment on branded queries. When your brand is mentioned in an AI answer, is the context accurate and neutral to positive, or built from outdated sources because your content gave the model nothing better to work with.

None of this replaces traditional SEO tracking. A brand can rank well organically while being nearly absent from AI-generated answers.

What to fix on your brand site this quarter

Most of these are technical fixes, achievable in a single quarter.

Schema markup. Structured data, including FAQPage, MedicalWebPage, and Drug schema where applicable, gives AI crawlers a clean way to parse content instead of guessing from unstructured text.
Transcripts for video and audio content. Any CME module, MSL webinar, or product video without a full text transcript is invisible to nearly every AI retrieval system in use today.
HCP-only crawlability review. Many brand sites gate HCP content behind login walls that also block legitimate crawlers, so your most clinically rigorous content may be the least visible to AI tools, while open consumer pages dominate instead.
Citation-worthy data pages. MOA, clinical trial, and safety data pages need real citations, publication dates, and text-based data tables rather than image-only charts, so they read as retrievable sources rather than marketing copy.
Structured safety content. Safety information needs an on-page, structured equivalent alongside any PDF, built for extraction.

These fixes do not require abandoning your content plan, only auditing what you have against how AI tools retrieve and summarize information.

The MLR question: approving content for AI-answer surfaces

MLR review was built around a page or a PDF with a fixed, final form. AI-answer surfaces break that assumption, because the same content can be summarized or rephrased by a model in ways the brand cannot preview in advance.

The practical answer is not to approve every possible AI-generated summary, which is not achievable. Instead, review should shift to approving source content with the understanding it may be extracted or compressed by a model. Reviewers should ask a new question during approval: does this claim hold up if pulled out of context and restated in a single sentence. Claims that only work with heavy qualification are a higher risk now.

Some teams are building a fast-track review lane for structured data pages, such as safety summaries and MOA content, because these are most likely to be pulled into AI answers. Getting ahead of this is far less costly than responding after an AI-generated answer misrepresents an already-approved claim.

FAQ

How are doctors actually using ChatGPT in clinical settings?

Physicians use ChatGPT for quick orientation on unfamiliar topics, drafting plain-language explanations for patients, prepping for CME sessions using browsing mode, and as a first stop before verifying with a clinical source.

What is HCP AI search behavior, and why does it matter for pharma marketing?

HCP AI search behavior refers to how physicians, PAs, NPs, MSLs, and pharmacists use tools like ChatGPT, Perplexity, Claude, and specialty models such as OpenEvidence during clinical decision moments. It matters because these tools are now a real entry point into how HCPs form impressions of a brand, often before they visit a brand website directly.

Do physicians trust AI search results as much as traditional clinical sources?

Most physicians treat general AI models as a starting point rather than a final authority, and verify high-stakes information against a trusted clinical source before acting on it. Specialty medical AI tools that show citations tend to earn more trust for evidence-based questions.

What is the difference between OpenEvidence and ChatGPT for clinical use?

OpenEvidence is built for evidence-based clinical questions and draws on indexed medical literature with visible citations, while ChatGPT is a general-purpose model used for a wider range of tasks, with less consistent sourcing for clinical claims.

How can pharma brands track whether they show up in AI-generated answers?

Brands can query the same AI tools their HCP audience uses, across a defined set of clinical and branded questions by indication, and track whether their content, a competitor's content, or no branded source appears. This should be repeated regularly, since answers shift as models update.

Does AI search replace the need for traditional pharma SEO?

No. Traditional SEO and AI-answer visibility are related but distinct. A brand can rank well in traditional search while being underrepresented in AI-generated answers, so both need tracking separately.

For more on AI search behavior, generative engine optimization, and the compliance questions that come with both, see:

Let's Talk HCP AI Search

If you want to know whether your brand shows up in the AI answers your HCPs are actually seeing, we can run a share of voice audit across the models your audience uses and show you where the gaps are. XDS Health has helped pharma and life sciences teams rebuild content structure for AI-answer visibility without losing MLR approval. Reach out through our contact page and we will set up a working session.